Name | 3-Methyl-1-phenyl-2-pyrazolin-5-one |
Synonyms | PMP MCI-186 Edaravone 1,3,5-PMP MONOPYRAZOLONE C.I. Developer 1 TIMTEC-BB SBB003801 1-Phenyl-3-Methyl-5-Pyrazole 3-methyl-1-phenyl-5-pyrazolon 1-Phenyl-3-Methyl-5-Pyrazolone 3-methyl-1-phenyl-2-pyrazolin-5-on 3-Methyl-1-phenyl-2-pyrazolin-5-one 2-Pyrazolin-5-one, 3-methyl-1-phenyl- 3H-Pyrazol-3-one,2,4-dihydro-5-methyl- 5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one 2,4-dihydro-5-methyl-2-phenyl-3h-pyrazol-3-on 2,4-dihydro-5-methyl-2-phenyl-3h-pyrazol-3-one |
CAS | 89-25-8 |
EINECS | 201-891-0 |
InChI | InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3 |
InChIKey | QELUYTUMUWHWMC-UHFFFAOYSA-N |
Molecular Formula | C10H10N2O |
Molar Mass | 174.2 |
Density | 1,12 g/cm3 |
Melting Point | 126-128°C(lit.) |
Boling Point | 287°C265mm Hg(lit.) |
Flash Point | 191°C/17mm |
Water Solubility | 3 g/L (20 ºC) |
Solubility | Soluble in hot water, alcohol, acid, alkali, slightly soluble in benzene, insoluble in ether, petroleum ether. |
Vapor Presure | 0.016Pa at 20℃ |
Appearance | Pale yellow crystalline powder |
Color | Yellow to beige |
Merck | 14,6713 |
BRN | 609575 |
pKa | 2.73±0.50(Predicted) |
PH | 4.0-4.4 (H2O, 20℃)(saturated aqueous solution) |
Storage Condition | 2-8°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
Sensitive | Air sensitivity |
Refractive Index | 1.6300 (estimate) |
MDL | MFCD00003138 |
Physical and Chemical Properties | Melting point 127-131°C boiling point 287°C (265 mmHg) water-soluble 3g/L (20°C) |
Use | Intermediates for the preparation of pyrazolone dyes and pharmaceuticals |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 1 |
RTECS | UQ9625000 |
TSCA | Yes |
HS Code | 29331990 |
Toxicity | LD50 orl-rat: 3500 mg/kg LONZA# 08FEB79 |
Reference Show more | 1. Xu Chenyu, Song Yingli, Wang Weiqian, Qin Wen, Wang Dan. Determination of mannose in compound capsule of dendrobium officinale [J]. Modern food, 2021(03):145-150. 2. [IF = 2.516] Nani Wang et al."Monosactride composition analysis of immunomodulatory polyaccharides by on‐line holow fiber microextraction with high‐performance liquid chromatography. J Sep Sci. 2016 Mar;39(5):818-826 3. [IF = 7.514] Jing Ma et al." The inhibition of pectin oligosacarides on degranulation of RBL-2H3 cells from apple pectin with high. "Food Chem. 2022 Mar;371:131097 4. [IF = 6.475] Mingchun Wen et al."Quantitative changes in monosaccharides of Keemun black tea and qualitative analysis of theaflavins-glucose adducts during processing."Food Res Int. 2021 Oct;148:110588 5. [IF=3.645] Jiayi Hu et al."Determination and analysis of monosaccharides in Polygonatum cyrtonema Hua polysaccharides from different areas by ultra-high-performance liquid chromatography quadrupole trap tandem mass spectrometry."J Sep Sci. 2021 Sep;44(18):3506-3515 6. [IF=5.165] Hongmei Zhang et al."Quality differentiation method of similar phytomedicines with high sugar content based on the sugar-marker: Taking Schisandrae Chinensis Fructus and Schisandrae Sphenantherae Fructus as an example."Arab J Chem. 2022 Apr;15:103727 7. [IF=5.396] Chunyin Qin et al."Comparison on the chemical composition, antioxidant, anti-inflammatory α-amylase and α-glycosidase inhibitory activities of the supernatant and cream from black tea infusion."Food & Function. 2022 Apr ;: |
white powder or crystal. Soluble in water, slightly soluble in ethanol or benzene, difficult to dissolve in cold water, petroleum ether, ether. Boiling Point (27. 33kPa)287 ℃. The melting point was 129-130 °c. Vapor pressure (20 °c) <1.33 PA. Refractive index 1.637.
This product is 3-methyl -1-phenyl -2-pyrazolin-5-one. The content of C10H10N2O shall not be less than 99.0% based on the dry product.
The melting point of this product is 126~130 ℃ (General 0612).
mainly used in the production of pharmaceutical antipyrine, aminopyrine, analgin. Also used in dyes (permanent yellow G, acid medium jujube BN, etc.) and color film dyes, pesticides and organic synthesis industry. And can be used as a chemical reagent for detecting vitamin B12,CO,Fe,Cu,Ni, etc.
take 0.50g of this product, add 50ml of water, shake for 10 minutes, filter, take the filtrate to determine according to law (General 0631) , pH value should be 4.5~5.5.
take this product O.lg, add 0901 ethanol to dissolve, the solution should be clear and colorless; If the color is colored, it should not be deeper compared with the yellow or yellow-green No. 1 Standard Colorimetric solution (General Principles first method).
new system for clinical use. Take an appropriate amount of this product, add the mobile phase to dissolve and dilute to make a solution containing about 1 mg per 1 ml, as a test solution; Take an appropriate amount of precision I, A solution containing about 1 ug per 1 ml was prepared as a control solution by quantitative dilution with the mobile phase. Test according to high performance liquid chromatography (General 0512). Silica gel bonded with eighteen alkyl silane was used as the filler; The mobile phase was methanol -0.05mol/L ammonium dihydrogen phosphate solution (adjusted to pH 20% with 3.5 phosphoric acid solution)(50:50); The detection wavelength was 245mn. Take an appropriate amount of reference substance of impurity I, add methanol to dissolve and dilute to make a solution containing about 2ug per lml, take lml, add human test solution (lml), mix well, and use as a system applicable solution, measure 10 u1, inject into liquid chromatograph, record chromatogram, the separation degree between edaravone peak and impurity I peak should be greater than 8.0. Take 10 u1 of the test solution and the control solution respectively, inject the human liquid chromatograph, record the chromatogram to 7 times of the retention time of the main component peak. If there is a chromatographic peak consistent with the retention time of impurity I in the chromatogram of the test solution, the peak area shall not be greater than the main peak area of the control solution (0.1% ) , other single impurity peak area shall not be greater than the main peak area of the control solution (0.1% ) , and the sum of each impurity peak area shall not be greater than 3 times (0.3%) of the main peak area of the control solution.
new system for clinical use. Take an appropriate amount of this product, precision weighing, adding mobile phase dissolution and quantitative dilution to make a solution containing about 1 mg per 1 ml, as a test solution; Take an appropriate amount of phenylhydrazine, precision weighing, the mobile phase was added to dissolve and quantitatively dilute to prepare a solution containing about 0.5ug per 1 ml as a control solution. Tested according to high performance liquid chromatography (General 0512). The mobile phase consisted of methanol -0.05mol/L ammonium dihydrogen phosphate solution (adjusted to pH 20% with 3.5 phosphoric acid solution)(25:75) and the detection wavelength was 226nm. 20 u1 of the test solution and the reference solution were respectively injected into the human liquid chromatograph, and the chromatograms were recorded. If there is a chromatographic peak consistent with the retention time of phenylhydrazine peak in the chromatogram of the sample and solution, the peak area shall be calculated according to the external standard method, and shall not exceed 0.05%.
take this product, at 60°C under reduced pressure drying to constant weight, weight loss should not exceed 0.5% (General rule 0831).
about l.Og of this product shall be taken and inspected according to law (General rule 0841). The remaining residue shall not exceed 0.1%.
The residue left under the item of burning and flooding shall be inspected according to law (general law 0821, Law II) and shall not contain more than 10 parts per million of heavy metals.
take this product about 0.32g, precision weighing, add ethanol 60ml, slightly heat to dissolve, cool, according to the potential titration method (General rule 0701), with sodium hydroxide titration solution (O. 1 mol/L) titration, and the results of the titration were corrected with a blank test. Each 1 ml of sodium hydroxide titration solution (0.1 mol/L) corresponds to 17.42mg of C10H10N2O.
free radical scavengers.
light shielding, sealed storage.
This product is a sterile aqueous solution of edaravone. The content of edaravone (C10H10N2O) should be 90.0% to 110.0% of the labeled amount.
This product is a colorless to yellowish (or yellowish green) clear liquid.
Same as edaravone.
(l)5ml:lOmg (2)10ml:15mg (3)20ml:30mg
light shielding, closed storage.
LogP | 0.75 at 24℃ |
NIST chemical information | information provided by: webbook.nist.gov (external link) |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
Introduction | edaravone is a new free radical scavenger, which was first launched in Japan in April, clinical mainly for the treatment of ischemic stroke. Edaravone exists in the form of anion, and can provide one electron to free radical to achieve the purpose of scavenging free radical. Because its molecular structure contains lipophilic groups, it is easy to reach the brain tissue through the blood-brain barrier, and has a protective effect on nerve cell injury caused by cerebral ischemia. |
mechanism of action | the protective mechanism of edaravone on nerve cells mainly includes scavenging oxygen free radicals and inhibiting lipid peroxidation, regulation of inflammatory factors, inhibition of apoptosis and so on. With the in-depth study of edaravone, it is found that in addition to the treatment of acute cerebral ischemia, edaravone has therapeutic effect on other diseases involving oxidative stress in the nervous system. In addition, edaravone also has a protective effect on other organs outside the nervous system. At present, Edaravone is mainly used for the treatment of ischemic stroke, but less in other clinical applications. |
indication | is suitable for improving neurological symptoms, activities of daily living and dysfunction caused by acute cerebral infarction. |
drug interaction | combined with cefazolin, piperacillin, cefotiam, etc. Mixed with potassium Cantali or antiepileptic drugs such as diazepam, phenytoin sodium can produce turbidity. |
preparation | a synthetic method of edaravone, comprising the following steps:(1) the hydrochloric acid solution or dilute sulfuric acid solution is cooled to 0~5 ℃ in an ice bath, and aniline solution is added dropwise thereto under stirring conditions. After the dropwise addition is completed, sodium nitrite solution is added dropwise thereto, maintain the temperature at 8~10 ℃, the dropping time is 1H, after the completion of all the dropping, keep the stirring reaction for a period of time, that is, to obtain the diazotization product;(2) step (1) the diazotization product was added dropwise to sodium bisulfite or sodium sulfite solution at 80~85 ℃ for 0.5~1H. After the addition, the mixture was kept for 30min and stirred; then heated reflux reaction for a period of time, and then add hydrochloric acid solution Dropwise, reflux acid after a period of time, to obtain phenylhydrazine hydrochloride;(3) step (2) after the reaction solution was cooled to room temperature, the pH was adjusted to 6 with aqueous ammonia, and ethyl acetoacetate was added dropwise thereto with vigorous stirring. The dropwise addition time was controlled to 1H, heating and refluxing, under the condition of stirring condensation reaction, after the reaction, stop heating, cooling Suction filtration, get light yellow edaravone crude product; |
Usage | It is mainly used for the synthesis of pyrazolone antipyretic analgesics such as metamizole, antipyrine and aminopyrine; it is also an intermediate for pyrazolone acid dyes such as the acid media jujube BN, permanent yellow G and color film dyes, pesticides and some other fine chemicals. intermediates for the preparation of pyrazolone dyes and pharmaceuticals used as reagents for the determination of cobalt, copper, iron, nickel, silver and vitamin B12, also used for dye synthesis used for the synthesis of antipyrine, aminopyrine, analgin and other drugs, preparation of acid media jujube red BN, yongguhuang G, leather spray dyes such as red G is mainly used in the production of drugs antipyrine, aminopyrine, the raw materials of the static, also used in dyes and color film dyes, pesticides and organic synthesis industry. 1. Mainly used in the production of pharmaceutical antipyrine, aminopyrine, analgin. Also used in dyes and color film dyes, pesticides and organic synthesis industry. And can be used as a chemical reagent for detecting vitamin B12,CO,Fe,Cu,Ni, etc. reagent for reducing carbohydrate detection by ESI/MALDI-MS method reagent for reducing carbohydrate detection by ESI/MALDI-MS. Environmental protection reagent |
production method | phenylhydrazine is obtained by reacting ethyl acetoacetate. Phenylhydrazine and ethanol were heated to about 50 ° C., and the addition of ethyl acetoacetate was started and refluxed for 4h after the addition. After a little cold, it was left overnight to precipitate yellow crystals, which were filtered, and the crude product was recrystallized with ethanol to be the finished product. Another method is the reaction of phenylhydrazine with butanone amide. Phenylhydrazine was reacted with butanone amide at about 50 ° C. After the reaction, the reaction was filtered, washed with water, and dried to obtain a finished product. Raw material consumption quota: aniline (98%)560kg/t, liquid ammonia 1100kg/t, hydrochloric acid (30%)1280kg/t, acetic acid 1060kg/t, sulfuric acid (93%)840kg/t, sulfur 850kg/t, ammonium nitrite (95%)440kg/t. |
toxic substance data | information provided by: pubchem.ncbi.nlm.nih.gov (external link) |